Sifuentes OJ, Donís HJ

Language: Spanish
References: 37
Page: 10-13
PDF size: 35.20 Kb.

Text Extraction

No abstract

REFERENCES

1. Levy SB. The antibiotic paradox: How miracle drugs are destroy the miracle. New York: Plenum, 1992.

2. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, et al. Antimicrobial resistance is a major threat to public health. (Editorial) BMJ 1998;317:764.

3. Wierup M. Preventive methods replace antibiotic growth promoters: Ten years experience from Sweden. News Letter of APUA 1998;16:2.

4. Witte W, Cuny C, Zimmermann O, Ruchel R, Hopken M, Fischer R, et al. Stability of genomic DNA fragment patterns in methicillin resistant Staphylococcus aureus (MRSA) during the course of intra- and interhospital spread. Eur J Epidemiol 1994;10:743-8.

5. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erithromycin resistance in a group a streptococci in Finland. NEJM 1997;337:441-4.

6. Bajanca-Lavado MP, Casin I, Vaz Pato MV. Antimicrobial resistance and epidemiological study of Haemophilus influenzae strains isolated in Portugal. The Multicentre Study Group. J Antimicrob Chemother 1996;38:615-25.

7. Caballero-Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Diez F, et al. Comparative study of bacteremias caused by Enterococcus spp with and without high-level resistance to gentamicin. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. J Clin Microbiol 1998;36:520-5.

8. Ostrowsky BE, Venkataraman L, D’Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: High frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999;159:1467-72.

9. Nowak R. Hungary sees an improvement in penicillin resistance. Science 1994;264:364.

10. Sahm DF, O’Brien TF. Detection and surveillance of antimicrobial resistance. Trends Microbiol 1994;2:366.

11. CNN News, Marzo 8, 1999.

12. Stelling JM, O’Brien T. Surveillance of antimicrobial resistance: The WHONET Program. Clin Infect Dis 1997;24(S):157-63.

13. O’Brien TF, Stelling JM. WHONET: An information system for monitoring antimicrobial resistance. Emerging Infectious Diseases 1995;1:66.

14. Ruiz-Palacios GM, Ponce de León S, Sifuentes J, Ponce deLeón S, Calva JJ, Huazano F, et al. Control of the resistance to aminoglycosides in gramnegative bacilli: Results of a three-year prospective study with the exclusive use of amikacin. Rev Invest Clin 1986;38:1-6.

15. Guzmán-Blanco M, Carmona O, Silva H, et al. Vigilancia de la resistencia bacteriana a los antibióticos en Venezuela. Gaceta Médica Caracas 1994;102:24.

16. Sifuentes-Osornio J, Donís-Hernández J, Arredondo-García JL, et al. Informe sobre resistencia bacteriana. Estudio piloto de seis centros de México. Rev Pan Infect 1999;3:45-47.

17. Levy SB. Antibiotic availability and use: Consequences to man and his environment. J Clin Epidemiol 1991;44 (suppl 2):83-87.

18. Strausbaugh LJ, Leitdke L. Emerging Infections Network: EIN participates in surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin. IDSA News 1998;8:13.

19. Report of a WHO workshop held in collaboration with the Italian Associazione Culturale. Microbiología Médica. The current status of antimicrobial resistance surveillance in Europe. Verona, Italy: 12 December 1997. WHO/EMC/ BAC/98.1.

20. European Society of Clinical Microbiology and Infectious Diseases. http://www.escmid.org/preview.html

21. European Society of Clinical Microbiology and Infectious Diseases. http://www.escmid.org/preview.html

22. Monnet D. European recommendations to respond to the threat of antimicrobial-resistant microorganisms: Specific actions are needed to address the ways in which antimicrobial resistance arises and deal with the problems that it causes. ASM News 1999;65(6):390-1.

23. Phillips I. The 1997 Garrod Lecture. The subtleties of antibiotic resistance. J Antimicrob Chemother 1998;42:5-12.

24. Davies J. In praise of antibiotics these “wonder drugs” revolutionized the treatment of infectious diseases-but they cannot be taken for granted. ASM News 1999;65(5):304-10.

25. Feinman SE. Antibiotics in animal feed - Drug resistance revisited. ASM News 1998;64(1):24-31.

26. Collignon P. Antibiotic use in animals. (Letter to the editor) ASM News 1999;65(4):187.

27. Fox JL. Senators ponder antibiotic resistance problem. ASM News 1999;(3):130.

28. Manual de calidad en guía para los laboratorios clínicos de América Latina. Editorial Panamericana, 1994:213.

29. Cruz JR. Conferencia “Sistemas de control de calidad”. En: Conferencia panamericana sobre resistencia antimicrobiana en las Américas. Caraballeda, Venezuela, 1998.

30. Mena A, Reyes C, Terrés SA. Monitor bacteriológico. México: Comunicaciones Científicas Mexicanas, 1998:1-12.

31. Ethical criteria for medical drug promotion. Geneva: World Health Organization, 1998.

32. Fefer E. Conferencia “Política regional, regulaciones y normas”. En: Conferencia panamericana sobre resistencia antimicrobiana en las Américas. Caraballeda, Venezuela, 1998.

33. WHO Expert committee on specifications for pharmaceutical preparation. Thirty-fourth report. Geneva: World Health Organization, 1997 (WHO technical report series, no. 863).

34. Acar JF, Goldstein FW. Consequences of increasing resistance to antimicrobial agents. Clin Infect Dis 1998;27 (suppl 1):S125-30.

35. Rahal K, Wang F, Schindler J, Rowe B, Cookson B, Huovinen P, et al. Reports on surveillance of antimicrobial resistance in individual countries. Clin Infect Dis 1997;24 (suppl 1):169-75.

36. Levy S, Cruz J. Two Americas Confront Antibiotic Resistance. ASM News 1999;65(3):132.

37. Shales DM, Gerding DN, John IF Jr., Craig WA, Bornstein DL, Duncan RA, et al. Society for healthcare epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-99.